Fin Tech Acquisition Corp

Journey Group Acquisition Co is a business based in Wilmington, DE that specializes in acquiring and managing a diverse portfolio of companies across various industries. With a focus on strategic investments and growth opportunities, the company aims to drive value and foster long-term success for its acquired businesses. Generated from their business information

NRx Pharmaceuticals, Inc., based in Wilmington, DE, is a clinical biopharmaceutical company dedicated to addressing the critical unmet needs of patients suffering from severe bipolar depression and post-traumatic stress disorder (PTSD), particularly in the context of suicidality. The company is pioneering innovative treatments, including NRX-101, the first oral medication in FDA trials for suicidal bipolar depression, aiming to transform mental health care. With a focus on non-hallucinogenic, non-addictive, and non-neurotoxic therapies, NRx Pharmaceuticals leverages novel approaches targeting the NMDA receptor to develop potential breakthroughs for those facing life-threatening mental health challenges. The organization emphasizes hope through its ongoing clinical trials and a commitment to improving the lives of individuals affected by these serious conditions. Generated from the website